Molecular diagnostic testing can involve significant upfront and per-test expenses due to the specialized cleanroom facilities, costly robotic instrumentation, proprietary enzymatic reagents, and expert bioinformatician labor required to process genetic samples. However, while individual test costs are higher than routine blood panels, they frequently lower total healthcare expenditures by preventing ineffective treatments and targeting therapies precisely.